TG Therapeutics (TGTX) EBITDA (2001 - 2026)
TG Therapeutics (TGTX) EBITDA from Dec 31, 2001 to Mar 31, 2026. The TTM TG Therapeutics (TGTX) EBITDA is $150M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
TG Therapeutics (TGTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +149.86% |
Annual EBITDA change of TG Therapeutics (TGTX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $35M | -71.77% |
| 2025 | $123M | +193.76% |
| 2024 | $42M | +101.54% |
| 2023 | $21M | -109.56% |
| 2022 | -$218M | -36.72% |
| 2021 | -$344M | +25.98% |
| 2020 | -$273M | +61.85% |
| 2019 | -$169M | -3.07% |
| 2018 | -$174M | +46.94% |
| 2017 | -$119M | +50.34% |
| 2016 | -$79M | +24.94% |
| 2015 | -$63M | +13.35% |
| 2014 | -$56M | +142.68% |
| 2013 | -$23M | -14.62% |
| 2012 | -$27M | +2955.68% |
| 2011 | -$880K | -135.06% |
| 2010 | $2.51M | -189.96% |
| 2009 | -$2.79M | -34.66% |
| 2008 | -$4.27M | -64.51% |
| 2007 | -$12M | +24.02% |
| 2006 | -$9.70M | -49.32% |
| 2005 | -$19M | +224.41% |
| 2004 | -$5.90M | -1.01% |
| 2003 | -$5.96M | +473.08% |
| 2002 | -$1.04M | +1633.33% |
| 2001 | -$60K | N/A |